Key Documents

View All Documentation

396931

Tetraheptylammonium bromide

Name: Tetraheptylammonium bromide
Brand: ALDRICH

Ion-Pair reagent, ≥99%

Select a Size

Change View

About This Item

Linear Formula:

[CH₃(CH₂)₆]₄N(Br)

CAS Number:

4368-51-8

Molecular Weight:

490.69

EC Number:

224-459-3

UNSPSC Code:

12352200

MDL number:

MFCD00011861

Beilstein/REAXYS Number:

3763391

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

grade

Ion-Pair reagent

assay

≥99%

mp

87-89 °C (lit.)

SMILES string

[Br-].CCCCCCC[N+](CCCCCCC)(CCCCCCC)CCCCCCC

InChI

1S/C28H60N.BrH/c1-5-9-13-17-21-25-29(26-22-18-14-10-6-2,27-23-19-15-11-7-3)28-24-20-16-12-8-4;/h5-28H2,1-4H3;1H/q+1;/p-1

InChI key

YQIVQBMEBZGFBY-UHFFFAOYSA-M

Description

Still not finding the right product?

Explore all of our products under Tetraheptylammonium bromide

pictograms

GHS07

signalword

Warning

hcodes

H315,H319,H335

pcodes

P261 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Development of simplified HPLC methods for the detection of counterfeit antimalarials in resource-restraint environments.

Ludwig Hoellein et al.

Journal of pharmaceutical and biomedical analysis, 98, 434-445 (2014-07-13)

Regular quality control and post-marketing surveillance of pharmaceuticals has been a critical challenge for countries of the developing world ever since. Counterfeit and substandard medicines are widely distributed and the real extent of their prevalence still remains unknown. Compendial protocols